A Phase 1 Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HH-101 in Patients With Advanced Solid Tumors
Clinical trial NCT07554196 · COMPLETED
Trial details
- NCT number
- NCT07554196
- Sponsor
- Huahui Health
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-19
- Primary completion
- 2023-08-09
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.